This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Ocular Drug Therapies / Oral Delivery of Macromolecules
October 26-27, 2022 | 2-Day Digital Conference
Digital Conference8:00AM EST // 1:00PM BST // 2:00PM CEST
Menu
Day 2 - Oral Delivery of Macromolecules - October 27thkeyboard_arrow_right

Day 2 - Oral Delivery of Macromolecules - October 27th - EST/EDT (Eastern Daylight, GMT-4)

keyboard_arrow_leftSearch & Filter
search
Day 2 - Oral Delivery of Macromolecules - October 27th - EST/EDT (Eastern Daylight, GMT-4)
search
Showing 1 of 1 Streams
Day 2 - Oral Delivery of Macromolecules - October 27th 08:00 - 08:05
Welcoming Remarks
  • Lottie Leinfellner - Digital Events Conference Producer, Informa Connect, UK
Day 2 - Oral Delivery of Macromolecules - October 27th 08:05 - 08:35
Overviewing the Landscape for Oral delivery of Macromolecules and a Look Forward to Future Developments in the Area
  • David Brayden - Full professor of Advanced Drug Delivery, Univesity College Dublin, Republic of Ireland
Day 2 - Oral Delivery of Macromolecules - October 27th 08:35 - 09:05
Gut Hormones Stimulation via Oral Delivery of Nanoparticles
  • Ana Beloqui Garcia - Assistant Professor & Research Associate, Université Catholique de Louvain, Belgium
Day 2 - Oral Delivery of Macromolecules - October 27th 09:05 - 09:35
Considerations in the Developability of Peptides for Oral Administration when Formulated Together with Transient Permeation Enhancers
  • Nigel Davies - Principal Scientist, Advanced Drug Delivery, AstraZeneca
Day 2 - Oral Delivery of Macromolecules - October 27th 09:35 - 10:05
Coffee Break & Networking
Day 2 - Oral Delivery of Macromolecules - October 27th 10:05 - 10:35
Developing Appropriate Models to Assess Intestinal Permeation Enhancers for Oral Delivery of Macromolecules
  • John Gleeson - Senior Scientist - Biopharmaceutics, Merck & Co., USA
Day 2 - Oral Delivery of Macromolecules - October 27th 10:35 - 11:05
Evaluating Epithelial Membrane Effects of Permeation Enhancers Investigated for Oral Peptide Delivery
  • Hanne Mørck Nielsen - Director, Center for Biopharmaceuticals and Biobarriers in Drug Delivery, Københavns Universitet, Denmark
Day 2 - Oral Delivery of Macromolecules - October 27th 11:05 - 11:25
Overcoming Bioavailability Challenges for Delivery of Diverse Range of Biologics using an orally ingestible autoinjector
  • Arvinder Dhalla - VP Clinical Development, Rani Therapeutics, USA
Day 2 - Oral Delivery of Macromolecules - October 27th 11:25 - 11:45
BIONDD – Effective Oral Delivery of Biomacromolecules
  • Karsten Lindhardt - CEO, Biograil, Denmark
Day 2 - Oral Delivery of Macromolecules - October 27th 11:45 - 12:05
Microneedle Pills for Biologic Drug Delivery
  • Alex Abramson - Assistant Professor, Georgia Institute of Technology, USA
Day 2 - Oral Delivery of Macromolecules - October 27th 12:05 - 12:35
Break & Networking
Day 2 - Oral Delivery of Macromolecules - October 27th 12:35 - 13:05
Oral Colon Targeted Delivery of Antibodies for Local Treatment of IBD
  • Vipul Yadav - Chief Executive Officer, Intract Pharma Ltd, UK
Day 1 - Ocular Drug Therapies - October 26th
Filter
Streams
Choose Day